1 research outputs found

    COVID-19 Vaccination Preferences of University Students and Staff in Hong Kong

    Get PDF
    IMPORTANCE: COVID-19 has required universities to rapidly develop vaccination policies for students and staff, yet little is known about the preferences of these individuals toward vaccination. OBJECTIVE: To quantify student and staff preferences for COVID-19 vaccination at a university in Hong Kong. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional online survey study was conducted from July 20 to September 21, 2021, before the announcement of a campus-wide vaccine mandate. A survey of 42β€―451 eligible university students and staff used discrete-choice experiment methods to quantify 7 attributes of COVID-19 vaccination: risk of a mild or moderate adverse event after vaccination, risk of a severe adverse event after vaccination, efficacy against COVID-19 infection, efficacy against severe manifestation of COVID-19 infection, duration of protection after vaccination, incentive for completing vaccination, and out-of-pocket costs. MAIN OUTCOMES AND MEASURES: A mixed logit regression model was used to estimate the preferences of attributes for COVID-19 vaccines and marginal willingness to pay (mWTP) adjusted for background characteristics, role, vaccination, and COVID-19 infection status of family or friends, adverse event status after vaccination among family and friends of participants, and scenario block. RESULTS: Among 42β€―451 eligible university students and staff invited, 3423 individuals completed the survey (mean [SD] age, 27.1 [9.9] years; 2053 [60.0%] women). Participants included 2506 students (73.2%) and 917 staff (26.8%), with a response rate of 8.1%. Quarantine-free travel was preferred (β = 0.86; 95% CI, 0.72-0.99; mWTP: 235.9;95235.9; 95% CI, 190.3-294.2),followedbyefficacyagainstanyCOVIDβˆ’19infection(β = 0.30;95294.2), followed by efficacy against any COVID-19 infection (β = 0.30; 95% CI, 0.29-0.32; mWTP: 84.1; 95% CI, 71.8βˆ’71.8-100.8), against severe manifestation of COVID-19 infection (β = 0.25; 95% CI, 0.24-0.27; mWTP: 69.7;9569.7; 95% CI, 465-653),andriskofsevereadverseeventsfollowingvaccination(β =β€‰βˆ’0.24;95653), and risk of severe adverse events following vaccination (β =β€‰βˆ’0.24; 95% CI, βˆ’0.27 to βˆ’0.21; mWTP: βˆ’66.8; 95% CI, βˆ’81.5toβˆ’81.5 to βˆ’55.3). Participants were less concerned about protection duration (β = 0.17; 95% CI, 0.15-0.18; mWTP: 46.0;9546.0; 95% CI, 38.6-56.2)andriskofmildtomoderateadverseevents(β =β€‰βˆ’0.12;9556.2) and risk of mild to moderate adverse events (β =β€‰βˆ’0.12; 95% CI, βˆ’0.13 to βˆ’0.10; mWTP: βˆ’32.7; 95% CI, βˆ’41.2toβˆ’41.2 to βˆ’26.4). CONCLUSIONS AND RELEVANCE: Preference of all attributes were significant and were considered important by the participants for vaccine decision-making. Insights drawn could assist policy makers in future vaccination decisions, such as campus vaccine mandate and requirement of a third dose
    corecore